Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Evaluating the Use of Ex Vivo Expanded Cord Blood Progenitors as Supportive Care Following Chemotherapy (FLAG) in Patients With AML or Acute Leukemia of Ambiguous Lineage

NCT01701323 is registered in ClinicalTrials.gov with Nohla Therapeutics, Inc. as lead sponsor.

NCT NCT01701323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01701323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Evaluating the Use of Ex Vivo Expanded Cord Blood Progenitors as Supportive Care Following Chemotherapy (FLAG) in Patients With AML or Acute Leukemia of Ambiguous Lineage
Lead sponsor
Nohla Therapeutics, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
December 10, 2012
Completion date
May 10, 2018
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia of ambiguous lineage, acute myeloid leukemia